MedTrace Logo

Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis

NCT03234517 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-08-07

No results posted yet for this study

Summary

Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis

Conditions

  • Bacterial Vaginosis Treatment

Interventions

DRUG

Vaginal Clindamycin Cream

Vaginal Clindamycin Cream

DRUG

Vaginal Probiotic

Vaginal Probiotic

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • Ibrahim A EL sharkwy · FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03234517 on ClinicalTrials.gov